News
ARHI Representatives Participate in Pfizer Path4ward Investigator Meeting in Orlando
Orlando, Florida, May 6th-8th, 2026 — Advanced Research for Health Improvement (ARHI) proudly participated in the recent Pfizer Path4ward Investigator Meeting held in Orlando, bringing together investigators, research professionals, and clinical trial leaders from across the country to collaborate on advancing innovative vaccine clinical research initiatives.
Representing ARHI at the meeting were delegates from two participating research sites involved in the Pfizer Path4ward Vaccines program:
- Site #1184 – Principal Investigator Dr. Shahzaib Mirza, represented by Site Director Juan C. Ramos
- Site #1185 – Principal Investigator Dr. MacKoul, represented by Sylvia Calvo and Kaitlin Brainerd
The investigator meeting provided an important opportunity for participating sites to engage directly with Pfizer clinical leadership, review study objectives, discuss operational strategies, and strengthen collaboration among participating research centers. The sessions focused on study implementation, patient engagement, protocol alignment, and the continued commitment to advancing high-quality clinical research.
ARHI representatives also attended the Welcome Reception hosted at the Rosen Centre Hotel in Orlando, where investigators and research teams connected with colleagues and sponsors in preparation for the upcoming study activities.
Participation in the Path4ward Investigator Meeting reflects ARHI’s continued dedication to supporting innovative research programs and expanding access to cutting-edge clinical trials within the communities it serves.
ARHI extends its appreciation to Pfizer and the Path4ward clinical operations team for organizing a successful and collaborative event that promotes excellence in clinical research and patient care.
